Gene drive organisms (GDOs) have been suggested as an approach to solve some of the most pressing environmental and public health issues. Currently, it remains unclear what kind of regulations are to be used to cover the potential risks. In their study, published in the open-access journal BioRisk, scientists evaluate the options for an operational risk assessment of GDOs before their release into environments across the EU.
- Injections are two-and-a-half times safer when nurses use revamped guidelines
- Cell ‘membrane on a chip’ could speed up screening of drug candidates for COVID-19
- Asthma does not seem to increase the severity of COVID-19
- Flashes bright when squeezed tight: How single-celled organisms light up the oceans
- Study indicates that Medicaid expansion has led to earlier cancer detection among individuals with low income